• Citer

Verapamil, a phenylalkylamine Ca2+ channel blocker, inhibits ATP-sensitive K+ channels in insulin-secreting cells from rats.

par Lebrun, Philippe ;Antoine, Marie-Hélène ;Ouedraogo, R;Pirotte, B;Herchuelz, André ;Cosgrove, Karen E;Kane, C;Dunne, Mark J
Référence Diabetologia, 40, 12, page (1403-1410)
Publication Publié, 1997-12

Article révisé par les pairs

• Détails
• Contenu

Titre:	Verapamil, a phenylalkylamine Ca2+ channel blocker, inhibits ATP-sensitive K+ channels in insulin-secreting cells from rats.
Auteur:	Lebrun, Philippe; Antoine, Marie-Hélène; Ouedraogo, R; Pirotte, B; Herchuelz, André; Cosgrove, Karen E; Kane, C; Dunne, Mark J
Informations sur la publication:	Diabetologia, 40, 12, page (1403-1410)
Statut de publication:	Publié, 1997-12
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adenosine Triphosphate -- pharmacology
	Animals
	Calcium -- metabolism
	Calcium Channel Blockers -- pharmacology
	Calcium Radioisotopes -- metabolism
	Female
	Gallopamil -- pharmacology
	Glucose -- pharmacology
	Glyburide -- pharmacology
	Hypoglycemic Agents -- pharmacology
	Insulin -- secretion
	Islets of Langerhans -- drug effects
	Islets of Langerhans -- secretion
	Potassium Channel Blockers
	Potassium Channels -- drug effects
	Pyridines -- pharmacology
	Rats
	Rubidium Radioisotopes -- metabolism
	Thiadiazines -- pharmacology
	Verapamil -- pharmacology
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0012-186X
	info:doi/10.1007/s001250050842
	info:scp/0031282931
	info:pmid/9447947